131 related articles for article (PubMed ID: 3498041)
1. Synovial membrane-cartilage interactions--the role of serine proteinase inhibitors in interleukin-1 mediated degradation of articular damage.
Ghosh P; Collier S; Andrews J
J Rheumatol; 1987 May; 14 Spec No():122-4. PubMed ID: 3498041
[TBL] [Abstract][Full Text] [Related]
2. A serine proteinase inactivator inhibits chondrocyte-mediated cartilage proteoglycan breakdown occurring in response to proinflammatory cytokines.
Bryson H; Bunning RA; Feltell R; Kam CM; Kerrigan J; Powers JC; Buttle DJ
Arch Biochem Biophys; 1998 Jul; 355(1):15-25. PubMed ID: 9647662
[TBL] [Abstract][Full Text] [Related]
3. The role of mononuclear cell products as modulators of cartilage degradation.
Mort JS; Campbell IK; Guttman A; Golds EE; Roughley PJ
J Rheumatol; 1987 May; 14 Spec No():86-7. PubMed ID: 3305942
[TBL] [Abstract][Full Text] [Related]
4. The role of plasminogen in interleukin-1 mediated cartilage degradation.
Collier S; Ghosh P
J Rheumatol; 1988 Jul; 15(7):1129-37. PubMed ID: 2971806
[TBL] [Abstract][Full Text] [Related]
5. Intercellular messengers in joint tissues in rheumatoid arthritis. How disturbed control mechanisms may contribute to tissue destruction and repair.
Russell RG; McGuire MK; Meats JE; Ebsworth NM; Beresford J
Scand J Rheumatol Suppl; 1981; 40():75-87. PubMed ID: 6100920
[TBL] [Abstract][Full Text] [Related]
6. A bovine hyaline cartilage proteinase inhibitor is active against some serine proteinases and inhibits the IL-1 alpha-mediated matrix degradation of bovine articular cartilage explants.
Arsenis C
Matrix Suppl; 1992; 1():321-2. PubMed ID: 1480051
[No Abstract] [Full Text] [Related]
7. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.
Hardy MM; Seibert K; Manning PT; Currie MG; Woerner BM; Edwards D; Koki A; Tripp CS
Arthritis Rheum; 2002 Jul; 46(7):1789-803. PubMed ID: 12124863
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
[TBL] [Abstract][Full Text] [Related]
9. Catabolin--a cartilage catabolic factor from synovium.
Dingle JT
Clin Orthop Relat Res; 1981 May; (156):219-31. PubMed ID: 7014063
[TBL] [Abstract][Full Text] [Related]
10. The role of serine proteinase in cartilage damage.
Lowther DA; Sriratana A; Bartholomew JS
J Rheumatol; 1987 May; 14 Spec No():49-51. PubMed ID: 3305940
[TBL] [Abstract][Full Text] [Related]
11. The role of serine proteinases and serine proteinase inhibitors in the pathobiology of connective tissues.
Ghosh P
Nihon Seikeigeka Gakkai Zasshi; 1989 May; 63(5):643-52. PubMed ID: 2794639
[No Abstract] [Full Text] [Related]
12. Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation.
van de Loo FA; Arntz OJ; van Enckevort FH; van Lent PL; van den Berg WB
Arthritis Rheum; 1998 Apr; 41(4):634-46. PubMed ID: 9550472
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes.
Recklies AD; Baillargeon L; White C
Arthritis Rheum; 1998 Jun; 41(6):997-1006. PubMed ID: 9627009
[TBL] [Abstract][Full Text] [Related]
14. Modulation of cartilage proteoglycan synthesis by osteoarthritic synovium.
Appel AM; Hopson CN; Herman JH
J Rheumatol; 1988 Oct; 15(10):1515-24. PubMed ID: 3204598
[TBL] [Abstract][Full Text] [Related]
15. Effect of synthetic metalloprotease inhibitors on cartilage autolysis in vitro.
Caputo CB; Sygowski LA; Wolanin DJ; Patton SP; Caccese RG; Shaw A; Roberts RA; DiPasquale G
J Pharmacol Exp Ther; 1987 Feb; 240(2):460-5. PubMed ID: 3543299
[TBL] [Abstract][Full Text] [Related]
16. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast activation protein alpha is expressed by chondrocytes following a pro-inflammatory stimulus and is elevated in osteoarthritis.
Milner JM; Kevorkian L; Young DA; Jones D; Wait R; Donell ST; Barksby E; Patterson AM; Middleton J; Cravatt BF; Clark IM; Rowan AD; Cawston TE
Arthritis Res Ther; 2006; 8(1):R23. PubMed ID: 16507127
[TBL] [Abstract][Full Text] [Related]
18. Effect of interleukin 1 and leukaemia inhibitory factor on chondrocyte metabolism in articular cartilage from normal and interleukin-6-deficient mice: role of nitric oxide and IL-6 in the suppression of proteoglycan synthesis.
Van de Loo FA; Arntz OJ; Van den Berg WB
Cytokine; 1997 Jul; 9(7):453-62. PubMed ID: 9237807
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and release of human cartilage matrix proteoglycans are differently regulated by nitric oxide and prostaglandin-E2.
Mastbergen SC; Bijlsma JW; Lafeber FP
Ann Rheum Dis; 2008 Jan; 67(1):52-8. PubMed ID: 17485421
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the role of metalloproteinases in recombinant human interleukin-1 beta-induced degradation of rat femoral head cartilage.
Seed MP; Thomson TA; Gardner CR
Drugs Exp Clin Res; 1991; 17(7):355-61. PubMed ID: 1794302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
